H26.31
Drug-induced cataract, right eye
Clinical Classification Guidelines
Medical Intelligence & Overview
A drug-induced cataract refers to a clouding of the lens in the eye caused by certain medications. When this condition affects the right eye specifically, it is labeled with the ICD-10 code H26.31. Cataracts can develop gradually and may impact vision significantly if not addressed. Recognizing the role of medications in cataract formation is essential for patients undergoing long-term drug therapy, especially with medications known to affect the lens.
Causes & Symptoms
Clinical Causes: Prolonged use of corticosteroids (such as prednisone) Certain antipsychotic medications Some diuretics Chemotherapy agents Medications with known cataractogenic potential, especially when used at high doses or over long periods Exposure to radiation therapy involving the eyes
Key Symptoms: Blurry or cloudy vision, particularly affecting one eye Sensitivity to light (photophobia) Reduced color perception or faded colors Difficulty seeing at night Need for brighter light when reading or doing close work Frequent changes in eyeglass prescription Presence of glare or halos around lights
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination by an eye care professional, including visual acuity testing and slit-lamp microscopy. The clinician will assess the clarity of the lens and determine if a cataract is present. Medical history review is critical to identify previous or ongoing use of medications associated with cataract development. Imaging studies or detailed lens examination may be performed to evaluate the extent and location of the clouding.
Treatment Protocols: The primary treatment for drug-induced cataracts, especially when vision impairment affects daily activities, is surgical removal of the cloudy lens, replaced with an artificial intraocular lens. Prior to surgery, discontinuation or substitution of the causative medication may be considered, depending on the clinical situation. Regular monitoring of eye health is essential to determine the progression of the cataract and plan timely intervention. Additionally, managing any underlying medical conditions and minimizing exposure to known cataract-inducing agents are important steps in overall care.
Clinical Advice & FAQs
Billing Guidance
Is H26.31 a billable ICD-10 code?
Yes, H26.31 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H26.31?
Clinical documentation must specify the nature of Drug-induced cataract, right eye and any associated comorbidities for accurate reporting.
Cite this Clinical Reference